LEADER 05060nam 2201177z- 450 001 9910637782803321 005 20231214133154.0 010 $a3-0365-5822-5 035 $a(CKB)5470000001631709 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/94587 035 $a(EXLCZ)995470000001631709 100 $a20202212d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMarine Glycomics 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (208 p.) 311 $a3-0365-5821-7 330 $aMarine creatures are rich sources of glycoconjugate-containing glycans and have diversified structures. The advance of genomics has provided a valuable clue for their production and developments. This information will encourage breeding and engineering functional polysaccharides with slime ingredients in algae. These glycans will have the potential for applications to antioxidant, anticancer, and antimicrobial drugs in addition to health supplements and cosmetics. The combination of both biochemical and transcriptome approaches of marine creatures will lead to the opportunity to discover new activities of proteins such as glycan-relating enzymes and lectins. These proteins will also be used for experimental and medical purposes, such as diagnostics and trial studies. The topic of marine glycomics is also focusing on understanding the physiological properties of marine creatures, such as body defense against pathogens and cancers. In the competitions for natural selection, living creatures have evolved both their glycans and their recognition. They have primitive systems of immunity, and few of their mechanisms are closely related to glycans. If we are able to describe the accumulation of data of glycans of creatures living in the seashore and the oceans, we may be able to anticipate a time when we can talk about the ecosystem with glycans. That knowledge will be useful for the development of drugs that cure our diseases and for an understanding of living systems in addition to the preservation of living environments. 606 $aResearch & information: general$2bicssc 606 $aBiology, life sciences$2bicssc 610 $aAcropora tenuis 610 $acoral 610 $achemoattraction 610 $alectin 610 $awhite-spotted charr lectin 610 $aoncolytic vaccinia virus 610 $ainterferon 610 $aantiviral response 610 $aChlorella vulgaris 610 $aDunaliella salina 610 $aArthrospira platensis 610 $agrowth rate 610 $aaccumulation of carbohydrates 610 $abiohydrogen 610 $aantibacterial activity 610 $aanticancer activity 610 $aantifungal activity 610 $aAplysia kurodai 610 $aapoptosis 610 $aEhrlich ascites carcinoma 610 $asulfated fucose-rich polysaccharides 610 $asulfated fucan 610 $afucosylated chondroitin sulfate 610 $afucoidan 610 $aoral administration 610 $aanticoagulant activity 610 $afucosylated glycosaminoglycan 610 $aanticoagulant 610 $aplatelet aggregation 610 $acontact activation 610 $ahypotension 610 $apulmonary embolism 610 $asulfated polysaccharides 610 $amarine hydrobionts 610 $aantiparasitic activity 610 $aprotozoa 610 $amalaria 610 $aleishmaniasis 610 $atrypanosomiasis 610 $aschistosomiasis 610 $acryptosporidiosis 610 $atrichomoniasis 610 $abivalve mollusk 610 $aC1q domain-containing 610 $alectin-like 610 $apattern recognition receptor 610 $apolysaccharides 610 $ainterstitial compartment 610 $amarine worms 610 $asipunculids 610 $abioactive properties 610 $apeptides 610 $arotifera 610 $apattern recognition receptors 610 $amicrobe-associated molecular patterns 610 $ainnate immunity 610 $aC-type lectins 610 $aC1q domain-containing proteins 610 $agalectins 610 $abacterial exopolysaccharides 610 $abioflocculanting activity 610 $amicroalgae growth-promoting bacterium 610 $aharmful algal bloom-forming dinoflagellate 610 $aAlexandrium catenella 610 $aMameliella alba 615 7$aResearch & information: general 615 7$aBiology, life sciences 700 $aFujii$b Yuki$4edt$01293295 702 $aGerdol$b Marco$4edt 702 $aOzeki$b Yasuhiro$4edt 702 $aFujii$b Yuki$4oth 702 $aGerdol$b Marco$4oth 702 $aOzeki$b Yasuhiro$4oth 906 $aBOOK 912 $a9910637782803321 996 $aMarine Glycomics$93022532 997 $aUNINA